EUVIMEDEUVIMED entdecken
Crossref

An in vitro feasibility study of 355 nm laser atherectomy for the treatment of peripheral atherosclerotic lesions

Hui Wang, Hui Zuo, Dikang Pan, Yihui Cao, Yiqun Zhang, Duan Liu, Lianrui Guo, Jianming Guo iD

Journal of Biophotonics · 2024

DOI: 10.1002/jbio.202400110 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biophotonics, 2024. Verfasst von Hui Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Vascular Surgery, Xuanwu Hospital, Capital Medical University, Beijing, China. Hauptthemen laut MEDLINE: Feasibility Studies, Atherectomy. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 37 Literaturangaben. Gefördert von: National Key Research and Development Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In this study, we utilized a novel 355 nm laser to ablate porcine aortas in the presence of physiological saline and contrast agent. Subsequently, we investigated the shape and depth of the resulting injuries. After ablating bovine tendons and aortas with the laser, we analyzed the size and quantity of particles postablation. Finally, we conducted ablation experiments using human ex vivo plaques. The analysis revealed minimal damage to porcine aortas within 2 s of exposure to the 355 nm laser. The degree of injury in the presence of contrast agent was higher than that in the presence of physiological saline but significantly lower than the damage caused by 308 nm laser. Regardless of whether it was bovine tendon or porcine aorta tissue, the proportion of particles

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Feasibility StudiesAtherectomyAnimalsSwineHumansCattleLaser TherapyAortaPlaque, Atherosclerotic

Stichwörter der Autor:innen

355 nmin vitrolaser atherectomylower extremities

Autor:innen und Institutionen

  • Department of Vascular Surgery, Xuanwu Hospital, Capital Medical University, Beijing, China.
  • Shenzhen Vivolight Medical Device & Technology Co. Ltd, Shenzhen, Guangdong Province, China.

ORCID-Profile: Jianming Guo

Förderung

  • National Key Research and Development Program of China

Zitieren

APA

Wang, H., Zuo, H., Pan, D., Cao, Y., Zhang, Y., Liu, D., Guo, L., & Guo, J. (2024). An in vitro feasibility study of 355 nm laser atherectomy for the treatment of peripheral atherosclerotic lesions. Journal of Biophotonics. https://doi.org/10.1002/jbio.202400110

Vancouver

Wang H, Zuo H, Pan D, Cao Y, Zhang Y, Liu D, et al. An in vitro feasibility study of 355 nm laser atherectomy for the treatment of peripheral atherosclerotic lesions. Journal of Biophotonics. 2024. doi:10.1002/jbio.202400110

BibTeX
@article{Wang2024,
  author = {Wang, Hui and Zuo, Hui and Pan, Dikang and Cao, Yihui and Zhang, Yiqun and Liu, Duan and Guo, Lianrui and Guo, Jianming},
  title = {An in vitro feasibility study of 355 nm laser atherectomy for the treatment of peripheral atherosclerotic lesions},
  journal = {Journal of Biophotonics},
  year = {2024},
  doi = {10.1002/jbio.202400110}
}
Kostenlos starten →